However, there is a concurrent increase in the expression of immunomodulatory molecules including Programmed Cell Death 1 (PD-1) on the infiltrating T cells (probably relating to their activation status), and Programmed Death 1 Ligand (PD-L1) in the tumor microenvironment.8 The gene discussed is PDCD1; the disease is neoplasm.